Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Cutan Pathol. 2010 Apr;37(4):411-5. doi: 10.1111/j.1600-0560.2009.01436.x. Epub 2009 Sep 24.

Immunohistochemical techniques to compare primary vs. metastatic mucinous carcinoma of the skin.

Author information

  • 1Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, USA. gillian.levy@yale.edu

Abstract

BACKGROUND:

Primary and metastatic mucinous carcinomas in skin are histologically indistinguishable. Immunohistochemical panels help differentiate primary and metastatic adenocarcinoma of skin, but data regarding mucinous carcinoma is scant.

METHODS:

We stained five primary mucinous carcinomas, two mucinous carcinomas metastatic to skin and five primary breast and colon mucinous carcinomas with p63, CD15, CK5/6, CK7, CK20, calponin and D2-40 to identify patterns that might differentiate primary from metastatic disease. We also searched for myoepithelial cells in all cases.

RESULTS:

All cases of primary mucinous carcinoma of the skin were positive for CK7, 40% showed rare cells labeled for p63 and 20% of cases labeled focally for CK5/6. The breast mucinous carcinomas metastatic to the skin were negative for all markers except CK7, although 60% of primary breast carcinomas labeled for p63. Colon mucinous carcinoma labeled only for CK20.

CONCLUSIONS:

In a small subset of mucinous carcinomas (20% in this series), positive labeling for CK5/6 indicated primary cutaneous tumor. Staining with p63 also favored primary over metastatic disease. Myoepithelial cell layers were not consistently identified to enable the identification of primary disease.

PMID:
19788442
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk